A detailed history of Mackenzie Financial Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,903 shares of BNTX stock, worth $447,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,903
Previous 3,903 -0.0%
Holding current value
$447,947
Previous $444,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$99.72 - $122.68 $1.93 Million - $2.38 Million
-19,370 Reduced 83.23%
3,903 $444,000
Q3 2024

Nov 13, 2024

BUY
$78.36 - $124.66 $486,380 - $773,764
6,207 Added 36.37%
23,273 $2.76 Million
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $1.05 Million - $1.34 Million
-13,023 Reduced 43.28%
17,066 $1.37 Million
Q1 2024

May 10, 2024

BUY
$88.96 - $112.35 $730,806 - $922,955
8,215 Added 37.56%
30,089 $2.78 Million
Q4 2023

Jan 30, 2024

BUY
$90.91 - $112.75 $1.52 Million - $1.89 Million
16,743 Added 326.31%
21,874 $2.31 Million
Q3 2023

Oct 25, 2023

BUY
$98.5 - $125.08 $234,430 - $297,690
2,380 Added 86.51%
5,131 $557,000
Q2 2023

Aug 03, 2023

BUY
$102.58 - $129.66 $44,211 - $55,883
431 Added 18.58%
2,751 $296,000
Q1 2023

Apr 24, 2023

SELL
$122.57 - $153.67 $800,382 - $1 Million
-6,530 Reduced 73.79%
2,320 $289,000
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $81,835 - $128,560
691 Added 8.47%
8,850 $1.33 Million
Q3 2022

Oct 07, 2022

BUY
$127.65 - $183.11 $434,775 - $623,672
3,406 Added 71.66%
8,159 $1.1 Million
Q2 2022

Aug 10, 2022

BUY
$123.25 - $186.24 $394,893 - $596,712
3,204 Added 206.84%
4,753 $709,000
Q1 2022

May 13, 2022

SELL
$126.25 - $231.85 $208,312 - $382,552
-1,650 Reduced 51.58%
1,549 $264,000
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $462,959 - $774,705
2,137 Added 201.22%
3,199 $825,000
Q3 2021

Nov 08, 2021

BUY
$205.93 - $447.23 $218,697 - $474,958
1,062 New
1,062 $290,000
Q1 2021

May 14, 2021

SELL
$85.73 - $119.5 $214,410 - $298,869
-2,501 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$72.71 - $129.54 $181,847 - $323,979
2,501 New
2,501 $204,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.9B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.